Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Mucositis
A listing of clinical trials currently looking for volunteers to enroll in Mucositis studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Mesa : Ironwood Cancer and Research Centers
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Arkansas
Hot Springs : St. Joseph's Mercy Cancer Center- Hot Springs Radiation Oncology
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
California
Chico : Enloe Medical Center- Cancer Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Concord : John Muir Medical Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Florida
Clearwater : Morton Plant Mease Health Care
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Gainesville : University of Florida College of Medicine
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Orlando : MD Anderson Cancer Center Orlando
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Tampa : H. Lee Moffitt Cancer Center
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Georgia
Columbus : John B. Amos Cancer Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Massachusetts
Boston : Dana Farber Cancer Institute
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Brockton : Signature Healthcare Brockton Hospital
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Nebraska
Omaha : Missouri Valley Cancer Consortium
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
New Mexico
Albuquerque : University of New Mexico Cancer Center
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
New York
Buffalo : VA Western New York Health System
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
New York : Beth Israel Medical Center
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
New York : Mount Sinai School of Medicine
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Poughkeepsie : Vassar Brothers Medical Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Syracuse : SUNY Upstate Medical University
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
North Carolina
Durham : Duke University Medical Center
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Gastonia : CaroMont Health Comprehensive Cancer Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Greenville : 21st Century Oncology- Carolina Radiation Medicine
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Ohio
Canton : Gabrail Cancer Center
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Middletown : Signal Point Clinical Research Center LLC
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Pennsylvania
Philadelphia : Temple University Hospital
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Philadelphia : Temple University Hospital
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Pittsburgh : Allegheny General Hospital
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Pittsburgh : University of Pittsburgh Medical Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
South Carolina
Spartanburg : Spartanburg Regional Medical Center
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Texas
Corpus Christi : Cancer Specialists of Southern Texas
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Dallas : University of Texas Southwestern Medical Center
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Houston : MD Anderson Cancer Center
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Washington
Bellingham : PeaceHealth St. Joseph Cancer Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Everett : Providence Hospital - Pacific Campus; Flynn Cancer Center
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Wisconsin
Milwaukee : Columbia St. Mary's Hospital
A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients
Australia
Adelaide : Adelaide Radiotherapy Centre
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Darlinghurst : St. Vincent's Hospital
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Herston : Royale Brisbane and Women's Hospital
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Austria
Salzburg : Univ. Klinik fur Innere Medizin III
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Vienna : Hanusch Krankenhaus
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
France
Besançon : Hospital Jean Minjoz
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Brest : CHU Morvan
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Caen : Centre François Baclesse
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Limoges : Clinique Chénieux
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Poitiers : CHU La Milétrie
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
View More »
Tours : Hôpital Bretonneau
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Germany
Freiburg : Universitatsklinikum Freiburg
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Homburg : University Medical School, Saarland
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
Korea, Republic of
Seoul : Seoul National University hospital
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
Seoul : Seoul National University Hospital
Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies
United Kingdom
Liverpool : Dr Howell
A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain
